These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22010922)

  • 21. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
    Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
    Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccination with 1/10th the full dose.
    Cooper CL; Davis H; Cameron DW
    N Engl J Med; 2004 Nov; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract]   [Full Text] [Related]  

  • 23. Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain.
    Farnsworth A; Cyr TD; Li C; Wang J; Li X
    Vaccine; 2011 Feb; 29(8):1529-33. PubMed ID: 21211583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus.
    Schofield DJ; Stephenson JR; Dimmock NJ
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2441-6. PubMed ID: 9349462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Towards a universal vaccine against flu?].
    Dreyfus C
    Med Sci (Paris); 2013 Jan; 29(1):22-5. PubMed ID: 23351688
    [No Abstract]   [Full Text] [Related]  

  • 27. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
    Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
    Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.
    Boudreau CM; Alter G
    Front Immunol; 2019; 10():440. PubMed ID: 30949165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in development of the influenza vaccine with broader cross-protection.
    Stropkovská A; Janulíková J; Varecková E
    Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keeping the memory of influenza viruses.
    Combadière B; Sibéril S; Duffy D
    Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine 1980-81.
    Clin Pediatr (Phila); 1980 Nov; 19(11):775-6. PubMed ID: 7428259
    [No Abstract]   [Full Text] [Related]  

  • 33. Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses.
    Schultz-Cherry S; Dybing JK; Davis NL; Williamson C; Suarez DL; Johnston R; Perdue ML
    Virology; 2000 Dec; 278(1):55-9. PubMed ID: 11112481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and optimization of a multiplex anti-influenza peptide immunoassay.
    Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR
    J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New horizons in influenza prevention].
    Sierra Madero JG
    Rev Invest Clin; 2000; 52(2):115-7. PubMed ID: 10846433
    [No Abstract]   [Full Text] [Related]  

  • 36. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
    Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
    Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
    Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing perspective on immunization against influenza.
    Johansson BE; Brett IC
    Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
    Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
    Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.